BioAdvance - Our Team
About BioAdvance >> Our Team

Our Management and Investment Team

Jeff D. Edelson, M.D., FRCPC, MHSc
Extramural Entrepreneur/Scientific Liaison

Dr. Edelson is executive vice president of research and development and chief medical officer of Intranasal Therapeutics Inc, of Saddle Brook, NJ, a specialty pharmaceutical firm. He is also the principal of Aequanimitas consulting LLC, a product development strategy and evaluation practice.

Jeff brings has over 20 years of clinical research and development experience. His prior industry experience includes senior leadership roles in areas of pulmonary and critical care medicine, oncology, hematology, supportive care and immunology for Johnson and Johnson, Aventis, Therion Biologics, SmithKline Beecham /GlaxoSmithkline. Dr. Edelson is also a seasoned technical product analyst and leader of multifunctional and alliance teams.

Prior to joining the pharmaceutical industry, Dr. Edelson was the founding Director of Research and Academic Affairs at the Health Sciences Research Centre at St. Michael’s Hospital in Toronto, Canada and a clinician / scientist and Assistant Professor of Medicine at the University of Toronto. His research endeavors spanned basic cell biology, translational medicine, clinical investigation and health service research.
 
Dr. Edelson holds an MD degree and an MHSc (Master of Health Sciences Administration) from the University of Toronto, Canada, where he trained in internal medicine and respiratory and critical care medicine, and where he was awarded a Robert Wood Johnson fellowship in 1997. He continues to teach part time in the Pulmonary and Critical Care program of the University of Pennsylvania, where he holds the rank of Adjunct Associate Professor of Medicine.